Global DR Screening: Why Aren’t We There Yet?

A look at the hope and hurdles of global screening implementation.

Majda Hadziahmetovic, MD; Michael D. Abramoff, MD, PhD; Abdullah AlQahtani, MD, DES, DISSO, FEBO; Gavin Tan Siew Wei, MBBS, PhD; Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth; Lloyd Harrison-Williams, MD; and Jorge C. P. Rocha, MD, PhD

What Pathogen Type Reveals About Endophthalmitis

Certain types of bacteria may be linked to a more aggressive disease course post-procedure.

Saagar Patel, MD; Christopher Conrady, MD, PhD; and Talisa E. De Carlo Forest, MD

Cancer-Associated Retinopathy With Thymic Carcinoma

A multimodal approach to treatment led to meaningful visual improvement despite poor prognostic signs on OCT.

Mena Kozman, MD; Aaron Shi, MD; Nyaari Kothiya; Sami Dahr, MD; and Rabia Karani, MD, MPH

Optimizing Functional Outcomes in PVR

Practical strategies and decision making for proliferative vitreoretinopathy surgery.

Neil Shah, MBBS, FRCOphth, and Rodrigo Anguita, MBBS, MD, FEBO, FICO